| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Thungela sells shares from 2021 plan for departing employees | ||
| Fr | BMO reiterates JBS stock Outperform on strong Q4 results | ||
| Fr | BofA cuts Eversource Energy price target on ROE reset concerns | ||
| Fr | BMO raises EQT stock price target to $76 on strong cash flow outlook | ||
| Fr | Quanta Services stock maintains Buy rating ahead of investor day | ||
| Fr | Humacyte shares see BTIG price target cut to $3 on lower sales outlook | ||
| Fr | UBS reiterates Fluor stock Buy rating on strong demand outlook | ||
| Fr | BofA raises WeRide stock price target on robotaxi fleet growth | ||
| Fr | Arhaus stock held at Hold by Jefferies on trade program launch | ||
| Fr | UBS reiterates Buy on National Vision stock, sees transformation | ||
| Fr | BMO sees AI expanding security threats after RSA Conference | ||
| Fr | Macquarie sees AI-driven attacks driving cybersecurity demand | ||
| Fr | Mizuho reiterates Axsome stock Outperform rating on Rx data | ||
| Fr | Mizuho downgrades Terns Pharmaceuticals stock rating on Merck deal | ||
| Fr | Carnival reports record Q1 results, launches $2.5B buyback | ||
| Fr | DA Davidson reiterates Shake Shack stock Buy rating on resilient customer base | ||
| Fr | Jones Trading reiterates Hold on Two Harbors stock after merger deal | ||
| Fr | DA Davidson reiterates Wingstop stock Buy rating, keeps $250 target | ||
| Fr | Electrica extends CEO, business development chief mandates | ||
| Fr | TMC March 2026 slides: $23.6B NPV project advances despite widening losses | ||
| Fr | Castle Biosciences presents melanoma test data at AAD meeting | ||
| Fr | Electrica approves $424m capex plan for 2026 | ||
| Fr | Lilly's Ebglyss shows four-year efficacy in eczema study | ||
| Fr | Meta data center deal to deliver $2B in Louisiana customer savings | ||
| Fr | AnaptysBio spinoff First Tracks Bio raises $80M in placement |